Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Bioline RX Ltd Sponsored ADR (BLRX)
NASDAQ:BLRX
RESEARCH TOOLSreports
Holding BLRX?
Track your performance easily
BLRX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.32 - $1.89
Previous Close$0.32
Volume2.06M
Average Volume (3M)485.55K
Market Cap
$31.31M
Enterprise Value$3.12M
Total Cash (Recent Filing)$42.99M
Total Debt (Recent Filing)$11.59M
Price to Earnings (P/E)―
Beta1.68
Next Earnings
Nov 25, 2024EPS Estimate
-$0.04Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.45
Shares Outstanding79,940,000
10 Day Avg. Volume431,066
30 Day Avg. Volume485,545
Standard Deviation0.20
R-Squared0.15
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)3.21
Price to Sales (P/S)8.93
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit2.82
Enterprise Value/Ebitda-0.23
Forecast
1Y Price Target
$2.00Price Target Upside582.13% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Bioline RX Ltd Sponsored ADR News
PremiumCompany Announcements
BiolineRx Ltd. Announces New Direct Offering of Shares
PremiumCompany Announcements
BioLineRx Granted Extension to Meet Nasdaq Requirements
PremiumCompany Announcements
BioLineRx’s Motixafortide Shows Promise in Sickle Cell Trials
PremiumCompany Announcements
BioLineRx Secures Extended U.S. Patent for Motixafortide
PremiumCompany Announcements
BioLineRx Ltd. Shareholders Approve Key ResolutionsOwnership Overview
―
Insiders
0.05% Mutual Funds
1.59% Other Institutional Investors
98.36% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
BLRX FAQ
What was Bioline RX Ltd Sponsored ADR’s price range in the past 12 months?
Bioline RX Ltd Sponsored ADR lowest stock price was $0.32 and its highest was $1.89 in the past 12 months.
What is Bioline RX Ltd Sponsored ADR’s market cap?
Currently, no data Available
When is Bioline RX Ltd Sponsored ADR’s upcoming earnings report date?
Bioline RX Ltd Sponsored ADR’s upcoming earnings report date is Nov 25, 2024 which is in 2 days.
How were Bioline RX Ltd Sponsored ADR’s earnings last quarter?
Bioline RX Ltd Sponsored ADR released its earnings results on Aug 15, 2024. The company reported $0 earnings per share for the quarter, beating the consensus estimate of -$0.075 by $0.075.
Is Bioline RX Ltd Sponsored ADR overvalued?
According to Wall Street analysts Bioline RX Ltd Sponsored ADR’s price is currently Undervalued.
Does Bioline RX Ltd Sponsored ADR pay dividends?
Bioline RX Ltd Sponsored ADR does not currently pay dividends.
What is Bioline RX Ltd Sponsored ADR’s EPS estimate?
Bioline RX Ltd Sponsored ADR’s EPS estimate is -$0.04.
How many shares outstanding does Bioline RX Ltd Sponsored ADR have?
Bioline RX Ltd Sponsored ADR has 79,990,616 shares outstanding.
What happened to Bioline RX Ltd Sponsored ADR’s price movement after its last earnings report?
Bioline RX Ltd Sponsored ADR reported an EPS of $0 in its last earnings report, beating expectations of -$0.075. Following the earnings report the stock price went down -12.821%.
Which hedge fund is a major shareholder of Bioline RX Ltd Sponsored ADR?
Among the largest hedge funds holding Bioline RX Ltd Sponsored ADR’s share is ARK Investment Management LLC. It holds Bioline RX Ltd Sponsored ADR’s shares valued at N/A.
---
Bioline RX Ltd Sponsored ADR Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$2.00 (582.13% Upside)
$2.00 (582.13% Upside)
Blogger Sentiment
Bullish
BLRX Sentiment 100%
Sector Average 72%
Sector Average 72%
Crowd Wisdom
Neutral
Last 7 Days ▼ 2.0%
Last 30 Days ▲ 1.5%
Last 30 Days ▲ 1.5%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-78.75%
12-Months-Change
Fundamentals
Return on Equity
-171.94%
Trailing 12-Months
Asset Growth
9.60%
Trailing 12-Months
Company Description
Bioline RX Ltd Sponsored ADR
BioLineRx Ltd. is a clinical-stage biopharmaceutical company, which includes indentifying, in-licensing, and developing therapeutic candidates. Its in-licenses novel compounds, primarily from academic institutions and biotech companies based in Israel, and develops them through pre-clinical and clinical stages, and then partners with pharmaceutical companies clinical development and commercialization. The company was founded in April 2003 and is headquartered in Modi'in, Israel.
---
BLRX Earnings Call
Q2 2024
0:00 / 0:00
---
BLRX Stock 12 Month Forecast
Average Price Target
$2.00
▲(582.13% Upside)
Technical Analysis
Best Analysts Covering BLRX
1 Year
1 Year Success Rate
0/10 ratings generated profit
1 Year Average Return
-49.10%
reiterated a buy rating 6 months ago
Copying Joseph Pantginis's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -49.10% per trade.
---